Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New tumor suppressor gene linked to cancer predisposition

21.04.2005


Scientists have identified a new gene that appears to be linked to a small but significant percentage of familial cancer cases – as well as seemingly randomly occurring malignancies.



The finding has scientists re-examining commonly held beliefs about the nature and frequency of genetic mutation as a cause of cancer. Familial cancer, in contrast to inherited cancer, is defined as multiple cases of cancer in one family that cannot be accounted for by classic rules of inheritance.

The findings are published in the April 21 issue of the New England Journal of Medicine.


“The findings suggest that a lot of cancer we once thought of as random may not be so random after all,” says George Calin, an adjunct assistant professor and research scientist in molecular virology, immunology and medical genetics and the first author of the study. He added that the findings hold important diagnostic and economic implications, as well.

Most geneticists believe that less than 5 percent of cancer is inherited, primarily through mutation in a relatively small number of well-known genes. Calin says that this new gene, however, dubbed ARLTS1, (ADP – Ribosylation Factor-Like Tumor Suppressor 1) can also increase a person’s chances of developing cancer, but only a little.

“ARLTS1 is one of an emerging set of genes whose effects are subtle, but which still play an important and predictable role in the development of cancer in some people.”

Researchers have known for years that a handful of well-known genes (like BRCA1 and BRCA2, for example) can, when mutated, dramatically increase a person’s risk of developing cancer. This “second tier” of genes, on the other hand, may heighten the risk of cancer for a much larger group of patients, says Carlo Croce, director of the Human Cancer Genetics Program at Ohio State and senior author of the study.

“Detecting alterations in such genes may more clearly predict who is predisposed to getting cancer, and who is not,” he adds.

Calin and Croce, both members of Ohio State’s Comprehensive Cancer Center, working with an international team of colleagues, had long suspected that a particular stretch of DNA on chromosome 13 – known as a rich source of mutations linked to various malignancies – might be the location of other genes important in carcinogenesis. Multiple tests with a portion of that DNA yielded ARLTS1 as a specific new gene.

ARLTS1 belongs to the Ras superfamily of genes that regulates cell growth. Most of the genes in that family are oncogenes, meaning that when activated, they cause cells to grow out of control. ARLTS1, on the other hand, is a tumor suppressor gene – a gene that normally helps the body identify and destroy suspicious-looking cells before they undergo malignant transformation and spread. When ARLTS1 is altered, it loses that ability, giving tumors a chance to establish themselves and grow.

To determine the extent to which ARLTS1 appears in various populations, researchers compared tumor tissue or blood samples from 325 patients with different forms of familial or sporadic cases of cancer to the blood of 475 healthy donors or patients with diseases other than cancer. The families, from the United States, France, Italy and Romania, included patients with chronic myeloid leukemia, or thyroid, colorectal, breast, lung or early stage pancreatic cancer.

Through multiple experimental and computational methods, researchers found that mutated ARLTS1 is three times more likely to be present in patients with familial cancers, and two times more likely to be present in random cases of cancer, than it is in the general population.

Calin says normal ARLTS1 activity can be compromised through deletion, mutation or alteration by a chemical change called methylation, adding that defective ARLTS1 also leads to inhibition of apoptosis, or normal cell death.

“We feel this discovery is significant on several levels. First, it adds one more player to the growing number of genes that are known to be active in the development of some forms of cancer,” says Croce.

“We also see this same gene mutated in small number of cancers that we once thought were randomly occurring in the general population. This is important for patients because one day in the near future, we will be able to incorporate a test for this gene – and others – into a simple screening tool that may reveal the extent to which a person is at risk for developing cancer.”

Calin says such tests could mean earlier detection of disease “which is not only good health, but good business.”

Grants from the National Cancer Institute, the Italian Ministry of Public Health and the Italian Association for Cancer Research supported the project.

Researchers from many cancer centers contributed to the study, including scientists from the Kimmel Cancer Center, Fox Chase Cancer Center; University of California at San Diego; Dana Farber Institute; University of Ferrara, Italy; Aarhus University, Denmark; Fundeni Hospital, Romania; University La Sapienza, Italy; Pasteur Institute, Paris; University of Catanzaro, Italy; Kyushu University, Japan; and Instituto Dermopatico dell’Immacolata, Italy.

Michelle Gailiun | EurekAlert!
Further information:
http://www.osu.edu

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>